Koyfin Home > Directory > Health Care > Incyte Corp > EBITDA Margin

Incyte Corp EBITDA Margin Chart (INCY)

Incyte Corp annual/quarterly EBITDA Margin from 1995 to 2018. An EBITDA margin is a measurement of a company's earnings before interest, taxes, depreciation, and amortization as a percentage of its total revenue.
  • Incyte Corp EBITDA Margin for the quarter ending December 12, 2018 was $19m a 163.50% increase of 32m year over year
  • Incyte Corp EBITDA Margin for the last 12 months ending December 12, 2018 was $11m a 164.28% increase of 18m year over year
  • Incyte Corp Annual EBITDA Margin for 2018 was $11m a 204.54% increase of 23m from 2017
  • Incyte Corp Annual EBITDA Margin for 2017 was $-12m a 249.00% decrease of -29m from 2016
  • Incyte Corp Annual EBITDA Margin for 2016 was $17m a 52.55% increase of 9m from 2015
Other Margins & Efficiency Metrics:
  • Incyte Corp Return on Capital % for the quarter ending December 12, 2018 was 11.86 a 177.05% increase of 20.99 year over year
  • Incyte Corp Return on Equity % for the quarter ending December 12, 2018 was 14.82 a 168.16% increase of 24.92 year over year
View Chart On Koyfin

Quarterly INCY EBITDA Margin Data

12/2018$19m
09/2018$11m
06/2018$20m
03/2018$-12m
12/2017$-25m
09/2017$6m
06/2017$8m
03/2017$-30m
12/2016$18m
09/2016$15m

Annual INCY EBITDA Margin Data

2018$11m
2017$-12m
2016$17m
2015$8m
2014$0m
2013$-3m
2012$1m
2011$-149m
2010$21m
2007$-210m